Because of the role of LAMP3 in tumor-associated hypoxia, future research is warranted to investigate whether LAMP3 plays a role in hypoxia-associated treatment failure and whether LAMP3 is a valid novel therapy target in gastrointestinal cancers. The gene discussed is LAMP3; the disease is neoplasm.